Poop pills aim to treat painful skin disease
NCT ID NCT06058520
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether taking capsules containing donor fecal bacteria can change the gut and skin bacteria of people with hidradenitis suppurativa (HS), a painful skin condition. Sixteen adults with HS will receive either the bacteria capsules or a placebo for three weeks. The main goal is to see if the donor bacteria take hold in the gut, not yet to measure symptom improvement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fecal microbiota (donor stool) in capsules
- What this could lead to
- If it works, this could point toward a new treatment option for hidradenitis suppurativa by changing gut bacteria.
- What could go wrong
- This is a very early, small pilot study with only 16 people. It primarily checks if the bacteria transfer works, not if it improves symptoms. Many early trials do not lead to effective treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55414, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could childhood trauma fuel skin inflammation?
- Head-to-Head: which pill tames hidradenitis suppurativa best?
- Skin disease evolution under the microscope: a 17-Year look at what drives severity
- Could early treatment tame a painful skin condition?
- New pill shows promise for controlling painful skin condition in long-term trial
- New shot could ease painful skin condition